Physiological aspects in magnetic drug-targeting

被引:253
作者
Lübbe, AS
Bergemann, C
Brock, J
McClure, DG
机构
[1] Cecilien Klin, D-33175 Bad Lippspringe, Germany
[2] Audax Inc, Leitchfield, KY 42754 USA
关键词
magnetic drug-targeting; magnetism; embolization; ferrofluids;
D O I
10.1016/S0304-8853(98)00574-5
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
The efficacy of magnetically-controlled drug targeting (MDT) depends on physiological parameters. To understand its mechanism of action on the tissue at the microcirculatory level, we identified the ferrofluids potential (its biological effects, its bioavailability and the in vivo desorption time of the anticancer drug epirubicin). Mechanical tumor embolization was possible, but successful tumor treatment was sometimes bypassed by a developing collateral circulation. Thus, MDT-treatment was used successfully in mice and in man. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:149 / 155
页数:7
相关论文
共 8 条
[1]  
BERGEMANN C, 1996, Patent No. 19624426
[2]   PRELIMINARY ELECTROPHYSIOLOGICAL DATA AFTER THE OBLITERATION OF COCHLEAR BLOOD-VESSELS BY THE ACTION OF A MAGNETIC-FIELD ON CIRCULATING IRON PARTICLES [J].
GIEBEL, W ;
WAGNER, H ;
SCHEIBE, F .
ARCHIVES OF OTO-RHINO-LARYNGOLOGY-ARCHIV FUR OHREN-NASEN-UND KEHLKOPFHEILKUNDE, 1985, 242 (03) :337-341
[3]  
GUPTA PK, 1993, MICROSPHERES REGIONA, P71
[4]   VENULES AND ARTERIOLES IN XENOTRANSPLANTED HUMAN COLON ADENOCARCINOMA CRITICALLY CONSTRICT WITH HYPERTHERMIA AND SEROTONIN [J].
HUHNT, W ;
LUBBE, AS .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1995, 121 (05) :267-274
[5]  
Lubbe AS, 1996, CANCER RES, V56, P4694
[6]  
Lubbe AS, 1996, CANCER RES, V56, P4686
[7]   EDRF AS A POSSIBLE MEDIATOR OF SEPSIS-INDUCED ARTERIOLAR DILATION IN SKELETAL-MUSCLE [J].
LUBBE, AS ;
GARRISON, RN ;
CRYER, HM ;
ALSIP, NL ;
HARRIS, PD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (03) :H880-H887
[8]  
WALLENSTEIN S, 1980, CIRC RES, V49, P1